Medical revenue increased 17.6% year-over-year in Q2 2025 Net loss improved by $7.6 million versus the prior year to $(3.7) million in Q2 2025; Adjusted EBITDA improved by $2.2 million versus the ...

US stocks close higher as investors price in a Fed rate cut soon and easing trade worries. EU delays retaliatory tariffs and Switzerland aims for deal ...